When Covid-19 entered the stage in the late spring of 2020, it changed everything that Jakob Gudbrand had imagined for the days to come.
Based out of Florida, and working as the president for Pharma & Biotech in the US lab giant Thermo Fisher Scientific, he has been responsible for major client relations and global strategy in pharma and biotech since January 2020 – and when the Covid-19 pandemic started wreaking havoc, he soon got a different role to play.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.